Oramed Pharmaceuticals (ORMP) Investor Presentation - Slideshow

Addressing the Multibillion-Dollar Injectable Drug Markets with Oral Formulations February 2020 Safe Harbor Certain statements contained in this material are forward-looking statements. These forward-looking statements are based on the current expectations of the management of Oramed only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including the risks and uncertainties related to the pr ...